FIND

How do we stop the spread of TB? We need simple, rapid and affordable tests that work for everyone, everywhere. Since 2010, FIND has worked with 17 countries to optimize their diagnostic networks. Ensuring you have the right kind of tests available in the right place leads to quicker results, fewer resources used, and better outcomes for the patients.

Did you know? 1 in 4 people worldwide carries the TB bacillus. Of those who carry the disease, only 5-10% will fall ill. Some risk factors for developing TB include: weakened immune systems, living with diabetes, living with HIV, and being malnourished, among others. Protect those around you – get tested and treated for TB.

Our request for proposal for a manufacturing and commercialization partner for an antigen-based rapid diagnostic test for Neisseria gonorrhoeae infection with a focus in low- and middle-income countries is still open! Link to have more details and to apply in the comments ⤵️

🚨New request for proposal: consultant for risk and compliance management 🚨 We are seeking the consultancy services of a risk and compliance specialist who will support putting in place robust systems to ensure compliance to the regulatory and institutional policies, and procedures that regulate our work. Submit your application before 1 April 2025! More details here: https://lnkd.in/e3XmWkRH

In case you have registered to the Women in Malaria online conference, don't forget to join the round table tomorrow on "What if women were leading the fight against malaria?". Our Scientist, Elena Marbán Castro, will join the discussion alongside esteemed speakers from 12:35 to 13:50 UTC. Full programme here: https://lnkd.in/dv4Nyim6

📢 Neonatal sepsis landscape survey: your input is needed! We are excited to announce our collaboration with NEST360 on a key initiative to improve neonatal sepsis diagnostics. As part of this effort, we are conducting a survey to gather valuable information and create a neonatal sepsis diagnostic landscape. We invite your company to participate and be featured in an online compendium showcasing innovative diagnostic solutions for neonatal sepsis. By participating, your company will: ✅ Gain global recognition in the health community ✅ Increase visibility and foster potential collaborations ✅ Highlight your product to customers actively seeking cutting-edge diagnostic tools Who should participate? - Companies with commercialized or in-development neonatal sepsis diagnostic solutions - Companies with adult sepsis diagnostics looking to expand into the neonatal space Note: tests based on single biomarkers (CRP, PCT) and blood culture are out of scope. Complete the survey by 31 March 2025 to contribute to this important global initiative to improve neonatal care worldwide! ⤵️ 🔗 https://lnkd.in/ep3ugyYA ❓ Have questions or need more details? Reach out to us at testdirectory@finddx.org! #NeonatalSepsis #Diagnostics #GlobalHealth #SepsisDiagnostics #NeonatalCare #InnovativeDiagnostics #GlobalHealthInnovation #NeonatalInnovation

Yesterday, our Director of Pandemic Threats, Dr Emmanuel Agogo MD MSc MtropMed FRCGP HonMFPH, gave an insightful presentation and joined a panel alongside speakers from Clinton Health Access Initiative, Inc., Everight Diagnostic & Laboratory Services Limited, and Codix Pharma Ltd at the National Summit on Diagnostics in Abuja, Nigeria. In his presentation and interventions, he shared lessons from the COVID-19 pandemic and opportunities in the field of pandemic preparedness, highlighting the need for better collaboration to build diagnostic capacity in countries like Nigeria. Key opportunities: 👉Developing a diagnostics preparedness roadmap 👉Strengthening biobanks & lab networks 👉Aligning with the WHO collaborative surveillance framework 👉Using data-driven strategies for pathogen diagnostics & outbreak response to benefit countries 👉Advocate for the deployment of tests in global discussions 👉Breaking silos between universal health coverage & health emergencies—they’re two sides of the same coin! It’s time to build strong partnerships and maximize resources!

Through the ACCEDE project, we are working to improve equity in access to continuous glucose monitoring (CGM)—a tool that can transform health and quality of life, ensuring that people living with diabetes have the tools they need to manage their condition effectively. More here: https://lnkd.in/etkGPZbr 📣Right now, children with type 1 diabetes in South Africa’s public sector don’t have access to CGM. To help children access the best diabetes care, SA Diabetes Advocacy is leading a critical advocacy push, calling on the South African National Department of Health to prioritize CGM access for children in the public sector. This important petition highlights the urgent need for better care and equity in diabetes management. 📝Stand with them and add your name to the petition today: https://lnkd.in/dHvsse9y #HealthForAll #DiagnosisForAll #DiabetesCare #DiabetesEquity #T1D

🚨New request for proposal🚨 We are seeking a manufacturing and commercialization partner for an antigen-based rapid diagnostic test for Neisseria gonorrhoeae infection with a focus on low- and middle-income countries. Apply before 2 April 2025! More information and application details here: https://lnkd.in/e3XmWkRH

In the lead up to World TB Day, we joined the first global #EndTBRun challenge organized by the World Health Organization in the Greater Geneva area, running alongside colleagues, friends, family members, and partner organizations. Have a look and learn more about the guidance to participate: https://lnkd.in/ec-CAR2g #EndTB